SRNE
Sorrento Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 2.14 Billion
Primary Exchange: NASDAQ CAPITAL MARKET
Website: https://sorrentotherapeutics.com/
Shares Outstanding: 263 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.4775189645508631
Sector:
Industry:
Ethical Flags
Longest drawdown: 1350 trading days
From: 2015-07-22 To: 2020-11-27
Lowest Point:
Sorrento to accelerate human IND filing of resiniferatoxin for neuropathic pain
via: SeekingAlpha at 2019-06-10 04:13:30:000
Sorrento Therapeutics (NASDAQ: SRNE ) to assign a high priority to exploring the use of resiniferatoxin as a local nerve block injection for the control of neuropathic post-amputation residual limb pain in humans. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Rea… read more...
Sorrento to accelerate human IND filing of resiniferatoxin for neuropathic pain
via: SeekingAlpha at 2019-06-10 04:13:30:000
Sorrento Therapeutics (NASDAQ: SRNE ) to assign a high priority to exploring the use of resiniferatoxin as a local nerve block injection for the control of neuropathic post-amputation residual limb pain in humans. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Rea… read more...
Sorrento to accelerate human IND filing of resiniferatoxin for neuropathic pain
via: SeekingAlpha at 2019-06-10 04:13:30:000
Sorrento Therapeutics (NASDAQ: SRNE ) to assign a high priority to exploring the use of resiniferatoxin as a local nerve block injection for the control of neuropathic post-amputation residual limb pain in humans. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Rea… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|